Form 4 for RXST RxSight, Inc.
Accepted 2023-08-11 00:00:00 ET · period of report 2023-08-09 · accession 0000950170-23-041859 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-11 | 2023-08-09 | RXST | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | +33.0K | 101.5K | +48% | $0 | |
| I | 2023-08-11 | 2023-08-09 | RXST | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | -497.1K | 994.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-09 | J | A | 32,950 | $0.00 | 101,546 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-09 | J | D | 497,150 | $0.00 | 994,313 | I See footnote | — | — | (F2) Shares held by LVP II. LCP II is the general partner of LVP II and may be deemed to have voting, investment and dispositive power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, and Patrick G. Enright are the managing members of LCP II and may be deemed to share voting, investment and dispositive power over the securities held by LVP II. LVP II, LCP II, Mr. Enright and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein. |